Apple’s push to keep Chinese chipmaker CXMT off the U.S. Entity List isn’t actually about lowering memory costs. According to industry analyst Ming-Chi Kuo, it reflects Apple’s recognition of a far more serious and longer-term problem: a widening global memory supply shortage that the company expects to persist well through 2027.
For years, the conversation around Apple’s component strategy has centered predominantly on cost management, with analysts and observers focused on how the company negotiates prices with its suppliers. But Kuo’s latest research reveals that the nature of the pressure on Apple has fundamentally shifted. The company is no longer primarily fighting soaring memory prices. Instead, it is contending with a critical supply gap that threatens its ability to manufacture enough devices to meet demand.
The Numbers Behind the Crisis
The scale of the supply problem is stark and difficult to overstate. In 2026, an estimated 15 to 20 percent of memory capacity that would otherwise be allocated to consumer electronics is expected to shift toward data centers, and by 2027 that share could grow even further as AI infrastructure investment continues to accelerate. For a company that depends on massive DRAM allocations across its iPhone, iPad, and Mac lineups, this broad reallocation of available capacity represents a genuinely serious constraint on production planning.
The impact of this shift is already becoming visible in Apple’s chip orders. Due to increasingly tight LPDDR memory supply, Apple’s actual pull-in volume of A20 chips for the second half of 2026 through the first quarter of 2027 could fall anywhere from 10 to 20 percent below its original target. Apple may have been aggressive in its initial bookings, which is consistent with its historical approach to supply chain management, but the projected shortfall still represents a material constraint that cannot easily be absorbed or papered over.
Why CXMT, and Why Now
CXMT itself is not a silver bullet solution to the memory supply problem. The Chinese memory manufacturer acknowledged in its IPO prospectus that its own production capacity falls far short of meeting domestic demand, which means that even if Apple’s lobbying effort succeeds and the company begins purchasing DRAM from CXMT, that relationship alone won’t meaningfully lower costs or fill the broader global supply gap in any significant way.
The real logic behind Apple’s lobbying, however, isn’t predicated on CXMT solving the problem outright. With the memory imbalance continuing to widen, Apple needs to identify and cultivate additional sources wherever they exist, and CXMT represents a potential backstop that could help the company manage supply risk across its product portfolio, even if its contribution remains modest in absolute terms.
This reasoning also helps explain why Apple is being far more proactive in pursuing CXMT today than it was when it evaluated YMTC back in 2022. That earlier effort was primarily oriented around lowering NAND flash costs, a fairly conventional supply chain negotiation. The CXMT situation is categorically different, driven not by a desire to reduce per-unit costs but by a genuine need to secure additional DRAM supply and reduce production risk in a market that is growing tighter by the quarter.
The Strategic Window
Tim Cook remains one of the very few technology executives capable of navigating both Washington and Beijing with any real effectiveness, and that rare combination of relationships and credibility matters enormously in a situation like this. There is also an implicit urgency to the timing, given that this kind of complex, relationship-driven lobbying effort is better pursued while Cook is still in the CEO role, since any future leadership transition would likely diminish Apple’s ability to manage this kind of delicate diplomacy with both the U.S. government and Chinese suppliers simultaneously.
Even if Apple’s lobbying ultimately fails to produce a favorable outcome, the effort itself serves a secondary and not insignificant purpose. The media coverage surrounding Apple’s attempt to secure an additional supply source creates a public narrative that Apple acted in good faith but was constrained by U.S. policy decisions, a framing that could help soften customer and investor frustration over price increases and extended delivery timelines in the quarters ahead.
The core issue, however, remains unchanged regardless of how the CXMT situation resolves: a global memory shortage with no simple or immediate fix is putting real pressure on Apple’s production capacity, and the company’s lobbying effort is best understood as a calculated bet that securing even one additional supply source might make that pressure slightly more manageable over time.
